Efficiency of Oseltamivir (Tamiflu) with Azithromycin Sustained Release (Zithromac SR) for inflammation.

Trial Profile

Efficiency of Oseltamivir (Tamiflu) with Azithromycin Sustained Release (Zithromac SR) for inflammation.

Completed
Phase of Trial: Phase II

Latest Information Update: 12 Sep 2012

At a glance

  • Drugs Azithromycin (Primary) ; Oseltamivir (Primary)
  • Indications Influenza A virus H1N1 subtype; Influenza A virus infections
  • Focus Biomarker; Pharmacodynamics
  • Most Recent Events

    • 23 Jul 2011 Actual end date (Apr 2011) as reported by University Hospital Medical Information Network - Japan
    • 23 Jul 2011 Status changed from active, no longer recruiting to completed as reported by University Hospital Medical Information Network - Japan
    • 06 Apr 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top